Abstract:Hemophagocytic lymphohistiocytosis (HLH) is a life-threatening condition characterized by the uncontrolled activation of cytotoxic T lymphocytes, NK cells, and macrophages, resulting in an overproduction of pro-inflammatory cytokines. A primary and a secondary form are distinguished depending on whether or not it is associated with hematologic, infectious, or immune-mediated disease. Clinical manifestations include fever, splenomegaly, neurological changes, coagulopathy, hepatic dysfunction, cytopenia, hypertriglyceridemia, hyperferritinemia, and hemophagocytosis. In adults, therapy, although aggressive, is often unsuccessful. We report the case of a 41-year-old man with no apparent history of previous disease and an acute onset characterized by fever, fatigue, and weight loss. The man was from Burkina Faso and had made trips to his home country in the previous five months. On admission, leukopenia, thrombocytopenia, increased creatinine and transaminases, LDH, and CRP with a normal ESR were found. The patient also presented with hypertriglyceridemia and hyperferritinemia. An infectious or autoimmune etiology was ruled out. A total body CT scan showed bilateral pleural effusion and hilar mesenterial, abdominal, and paratracheal lymphadenopathy. Lymphoproliferative disease with HLH complication was therefore suspected. High doses of glucocorticoids were then administered. A cytologic analysis of the pleural effusion showed anaplastic lymphoma cells and bone marrow aspirate showed hemophagocytosis. An Epstein-Barr Virus (EBV) DNA load of more than 90000 copies/mL was found. Bone marrow biopsy showed a marrow localization of peripheral T lymphoma. The course was rapidly progressive until the patient died. HLH is a rare but usually fatal complication in adults of hematologic, autoimmune, and malignant diseases. Very early diagnosis and treatment are critical but not always sufficient to save patients.

Hemophagocytic lymphohistiocytosis: mechanisms of development, clinical manifestations, and treatments

History of Hemophagocytic Lymphohistiocytosis

Dilemmas in diagnosis and management of hemophagocytic lymphohistiocytosis in children

Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms

Associations Between Inflammatory Cytokines and Organ Damage in Pediatric Patients with Hemophagocytic Lymphohistiocytosis.

Studies on the Early Diagnosis and the Intervention for Children with Hemophagocytic Lymphohistiocy-Tosis

Advances in understanding the pathogenesis of HLH

Hemophagocytic lymphohistiocytosis: A disorder of T cell activation, immune regulation, and distinctive immunopathology

Pathogenesis of Hemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome: A Case Report and Review of the Literature

Cytokine storm and targeted therapy in hemophagocytic lymphohistiocytosis

Hemophagocytic Syndrome in Children and Adults

Advances in Hemophagocytic Lymphohistiocytosis: Pathogenesis, Early Diagnosis/Differential Diagnosis, and Treatment

Understanding the spectrum of haemophagocytic lymphohistiocytosis: update on diagnostic challenges and therapeutic options

Clinical case of hemophagocytic lymphohistiocytosis: rare or undiagnosed syndrome?

[Research Advance on Hemophagocytic Lymphohistiocytosis].

[Research Advances in the Pathogenesis, Diagnosis and Treatment of Hemophagocytic Lymphohistiocytosis in Children].

Rare diseases presenting with hemophagocytic lymphohistiocytosis

Hemophagocytic lymphohistiocytosis and macrophage activation syndrome: two rare sides of the same devastating coin

Malignancy-associated haemophagocytic lymphohistiocytosis

Current status of the diagnosis and treatment of hemophagocytic lymphohistiocytosis in adults

Hemophagocytic Lymphohistiocytosis mimics many common conditions: case series and review of literature